Related references
Note: Only part of the references are listed.Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria
M. A. Pfaller et al.
DRUG RESISTANCE UPDATES (2011)
Use of Epidemiological Cutoff Values To Examine 9-Year Trends in Susceptibility of Candida Species to Anidulafungin, Caspofungin, and Micafungin
M. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
FKS Mutations and Elevated Echinocandin MIC Values among Candida glabrata Isolates from U.S. Population-Based Surveillance
Alicia J. Zimbeck et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Novel FKS Mutations Associated with Echinocandin Resistance in Candida Species
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Breakthrough Invasive Candidiasis in Patients on Micafungin
Christopher D. Pfeiffer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β-D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during Candidemia treatment
John D. Cleary et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Survey of vaginal-flora candida species isolates from women of different age groups by use of species-specific PCR detection
John-Paul Vermitsky et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Resistance to echinocandin-class antifungal drugs
David S. Perlin
DRUG RESISTANCE UPDATES (2007)
Pdr1 regulates multidrug resistance in Candida glabrata:: gene disruption and genome-wide expression studies
John-Paul Vermitsky et al.
MOLECULAR MICROBIOLOGY (2006)
Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility
Santosh Katiyar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Promoter-dependent disruption of genes: simple, rapid, and specific PCR-based method with application to three different yeast
TD Edlind et al.
CURRENT GENETICS (2005)
Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States
L Ostrosky-Zeichner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida Vaginitis: Clinical implications
JD Sobel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Share Paper
